| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 01/02/2003 | EP1268439A1 5-hydroxy indazole derivatives for treating glaucoma |
| 01/02/2003 | EP1268438A1 6-hydroxy-indazole derivatives for treating glaucoma |
| 01/02/2003 | EP1268437A1 Inhibitors of protein kinases |
| 01/02/2003 | EP1268430A1 Chemical complex compprising a pyridine carboxy derivative and an h2 histamine receptor antagonist |
| 01/02/2003 | EP1268429A1 Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same |
| 01/02/2003 | EP1268418A1 Pharmaceutically active pyrrolidine derivatives as bax inhibitors |
| 01/02/2003 | EP1268404A1 Malonamic acids and derivatives thereof as thyroid receptor ligands |
| 01/02/2003 | EP1267935A2 Novel treatment for eye disease |
| 01/02/2003 | EP1267910A2 Methods for inducing angiogenesis using morphogenic proteins and stimulatory factors |
| 01/02/2003 | EP1267903A1 Methods for treating glaucoma |
| 01/02/2003 | EP1267894A2 Viscoelastics for use in middle ear surgery |
| 01/02/2003 | EP1267882A2 Apoptosis inhibitor with prostaglandin structure |
| 01/02/2003 | EP1267878A2 Compounds with 5-ht activity useful for controlling visual field loss |
| 01/02/2003 | EP1267875A1 Sigma receptor ligands and their medical uses |
| 01/02/2003 | EP1267847A2 5ht 2 agonists for controlling iop and treating glaucoma |
| 01/02/2003 | EP1267839A2 Microspheres for active embolization |
| 01/02/2003 | EP1267827A2 Method for treating dry eye |
| 01/02/2003 | EP1267826A1 Pharmaceutical composition for treatment of mucosal epithelial ulceration and/or erosion |
| 01/02/2003 | EP1267806A2 Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives |
| 01/02/2003 | EP0806960B1 Extracts of shark cartilage, process of production and uses thereof |
| 01/02/2003 | EP0771216B9 Methods and compositions for the specific coagulation of tumoral vasculature |
| 01/01/2003 | CN1387846A Intraocular pressure reducing agent |
| 12/31/2002 | US6500864 Disulfide derivatives useful for treating allergic diseases |
| 12/31/2002 | US6500856 For therapy of inflammatory diseases and other diseases involving elevated levels of cytokines and proinflammatory mediators |
| 12/27/2002 | WO2002103027A1 Glycoprotein and process for producing the same |
| 12/27/2002 | WO2002102973A2 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof |
| 12/27/2002 | WO2002102972A2 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof |
| 12/27/2002 | WO2002102854A2 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof |
| 12/27/2002 | WO2002102836A2 Moraxella (branhamella) catarrhalis antigens |
| 12/27/2002 | WO2002102771A1 Tryptase inhibitors |
| 12/27/2002 | WO2002102403A1 Mucosal repair by tff dimer peptides |
| 12/27/2002 | WO2002102399A2 Mucosal repair by tff2 peptides |
| 12/27/2002 | WO2002102389A1 3, 7 or 3 and 7 thia or oxa prostanoic acid derivatives as agents for lowering intraocular pressure |
| 12/27/2002 | WO2002102369A2 Agent for protection of retinal neurons |
| 12/27/2002 | WO2002102310A2 Proteins associated with cell growth, differentiation, and death |
| 12/27/2002 | WO2002070473A3 Carboxamide derivatives as therapeutic agents |
| 12/27/2002 | WO2002066620A3 Pigmentary epithelium cell of the eye, the production thereof and the use of the same for treating diseases of the eye or of the central nervous system |
| 12/27/2002 | WO2002060454A3 Use of dinucleoside polyphosphate to stimulate removal of fluid in retinal disorders |
| 12/27/2002 | WO2002058668A3 Artificial tear composition adapted to be used with contact lenses |
| 12/27/2002 | WO2002055099A3 Modulation of pericyte proliferation using bpi protein products or bpi inhibitors |
| 12/27/2002 | WO2002018445A8 Co-crystal structure of monoclonal antibody 5c8 and cd154, and use thereof in drug design |
| 12/27/2002 | WO2002012467A3 Drug metabolizing enzymes |
| 12/27/2002 | WO2002009702A3 Use of indole derivatives for the manufacture of a medicament for reducing intracular pressure |
| 12/27/2002 | WO2001087935A9 Methods of modulating angiogenesis by regulating the expression of pituitary tumor transforming gene (pttg) |
| 12/27/2002 | CA2455254A1 Moraxella (branhamella) catarrhalis antigens |
| 12/27/2002 | CA2451475A1 Agent for protection of retinal neurons |
| 12/27/2002 | CA2450793A1 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof |
| 12/27/2002 | CA2450659A1 Tryptase inhibitors |
| 12/27/2002 | CA2450067A1 Proteins associated with cell growth, differentiation, and death |
| 12/26/2002 | US20020198266 Skin remedy, which allows gas transportation therethrough |
| 12/26/2002 | US20020198248 Therapeutic methods and compositions involving isoflavones |
| 12/26/2002 | US20020198210 Alpha-2-adrenergic agonist/fatty acid compositions |
| 12/26/2002 | US20020198177 Coenzyme Q and EPA |
| 12/26/2002 | US20020198174 Disinfecting and solubilizing steroid compositions |
| 12/26/2002 | US20020198143 B7-like polynucleotides, polypeptides, and antibodies |
| 12/26/2002 | US20020197298 Interior core in well containing active materials; aperture to exterior |
| 12/26/2002 | US20020197210 Stabilized therapeutic and imaging agents |
| 12/25/2002 | CN1387531A Pyrazolo [4,3-d] pyrimidine derivs. |
| 12/25/2002 | CN1387528A Heterocyclic substd, pyrazolones |
| 12/25/2002 | CN1387527A Qinazoline derivs. as VEGF inhibitors |
| 12/25/2002 | CN1387514A Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
| 12/25/2002 | CN1387505A Compositions contg. hydroxyeicosatetraenoic acid derivs, and methods of use in treating dry eye disorders |
| 12/25/2002 | CN1387504A Omega-chain modified 15-hydroxyeicosatetraenoic acid derivatives and methods of their use for treatment of dry eye |
| 12/25/2002 | CN1387503A Hydroxyeicosatetraenoate salts, composition and method of use in treating dry eye disorders |
| 12/25/2002 | CN1387502A 15-hydroxyeicosatetraenoic acid-related compounds and methods of use |
| 12/25/2002 | CN1387436A Preventive and therapeutic agents for eye diseases |
| 12/25/2002 | CN1387435A Lipoxin A4 and its analogs for treatment of dry eye |
| 12/25/2002 | CN1386508A Artificial tear containing chitosan and its preparing process |
| 12/25/2002 | CN1096854C GABA-ergic modulation of eye growth |
| 12/24/2002 | US6498191 For treatment of alzheimer's disease, diabetes mellitus, parkinson's disease, neuronal and cardiac ischemia, huntington's disease, stroke |
| 12/24/2002 | US6498177 Alpha 2 adrenergic receptor agonist; analgesic, sedative and anaesthetic agents |
| 12/24/2002 | US6498172 Prostaglandin agonists and their use to treat bone disorders |
| 12/24/2002 | US6498162 Treating inflammatory and allergic diseases of respiratory tract and diseases of central nervous system |
| 12/24/2002 | US6498158 Il-5 inhibiting 6-azauracil derivatives |
| 12/24/2002 | US6498148 Immunization-free methods for treating antigen-stimulated inflammation in a mammalian host and shifting the host's antigen immune responsiveness to a Th1 phenotype |
| 12/24/2002 | CA2278802C Ophthalmic compositions including glycerin and propylene glycol |
| 12/21/2002 | CA2390966A1 Compound for the treatment of atherosclerotic-thrombotic pathological conditions |
| 12/19/2002 | WO2002100859A1 Pde iv inhibitors |
| 12/19/2002 | WO2002100858A2 Quinuclidine-substituted heteroaromatic compounds as ligands at nicotinic acetylcholine receptors |
| 12/19/2002 | WO2002100857A1 Quinuclidines-substituted-multi-cyclic-heteroaryls for the treatment of disease |
| 12/19/2002 | WO2002100833A1 Rho KINASE INHIBITORS |
| 12/19/2002 | WO2002100486A1 Method and apparatus for treating uterine myoma |
| 12/19/2002 | WO2002100437A2 Ophthalmic compositions comprising hyaluronic acid |
| 12/19/2002 | WO2002100436A2 Ophthalmic once-a-day composition |
| 12/19/2002 | WO2002100408A2 Treating neuropathic/inflammatory pain by targeting a composition (e.g. zd7288) to hcn pacemaker channels |
| 12/19/2002 | WO2002100388A2 Cyclopentane heptan (ene) acyl sulfonamide, 2-alkyl or 2-arylalkyl, or 2-heteroarylalkenyl derivatives as therapeutic agents for the treatment of ocular hypertension |
| 12/19/2002 | WO2002100376A1 Ophthalmic compositions comprising chitosan and an active substance, in particular ketotifen, and use thereof for the treatment of ocular allergic conditions |
| 12/19/2002 | WO2002100341A2 Compounds for the treatment of metabolic disorders |
| 12/19/2002 | WO2002100330A2 METHODS OF ADMINISTERING ANTI-TNFα ANTIBODIES |
| 12/19/2002 | WO2002100328A2 Treating pain by targeting hyperpolarization-activated, cyclic nucleotide-gated channels |
| 12/19/2002 | WO2002100309A1 Quinolone carboxylic acid compositions and related methods of treatment |
| 12/19/2002 | WO2002100293A2 A diagnostic and prognostic method for evaluating ocular inflammation and oxidative stress and the treatment of the same |
| 12/19/2002 | WO2002085906A3 Phthalazinones derivatives useful as pde4/7 inhibitors |
| 12/19/2002 | WO2002064755A3 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 12/19/2002 | WO2002060894A3 Sulfonamide lactam inhibitors of factor xa |
| 12/19/2002 | WO2002059080A3 Trisubstituted carbocyclic cyclophilin binding compounds and their use |
| 12/19/2002 | WO2002058626A9 Methods and compositions for the identification and treatment of neurodegenerative disorders |
| 12/19/2002 | WO2002057222A3 Thiol-based naaladase inhibitors |
| 12/19/2002 | WO2002055501A3 N-pyridyl carboxamide derivatives and pharmaceutical compositions containing them |
| 12/19/2002 | WO2002005795A3 Pharmaceutical combinations for treatment and prevention of diabetes mellitus |